Advertisement

Panel Recommends New, Better Shingles Shot

Panel Recommends New, Better Shingles Shot

MIKE STOBBE, AP Medical Writer
October 25, 2017 06:45 PM

NEW YORK (AP) - A federal panel is recommending that older people vaccinated for shingles get a new, better shot approved last week.

Advertisement – Content Continues Below

The advisory panel on Wednesday said the vaccine made by GlaxoSmithKline works better than the first one made by Merck, which has been sold in the U.S. since 2006. Health officials say many as 20 million Americans should get a second round.

Shingles, a painful blistery condition, occurs when the chickenpox virus resurfaces later in life. Merck's vaccine is recommended for people 60 and older. But health officials say its effectiveness drops sharply after about five years.

The Advisory Committee on Immunization Practices said doctors should first opt for Glaxo's Shingrix, licensed last week, which uses a new ingredient to boost its effectiveness. It was recommended for people 50 and older.


Credits

MIKE STOBBE, AP Medical Writer

Copyright 2017 The Associated Press. All rights reserved.

Advertisement
Advertisement
Relay Media Amp

Bad River Tribal Members Voice Concerns About Sheriff's Department

St. John's Catholic Church Serves Christmas Dinner

LSC Graduates Celebrate with Pinning Ceremony

UMD Professor Weighs in on Local Impacts of GOP Tax Bill

Duluth Police Say Car Thefts Spiked in 2017

Crisis Intervention Training for Range Police Officers

Advertisement